This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kumamoto University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Haruki Horiguchi: Innovator in Heart Failure Treatment
Introduction
Haruki Horiguchi is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of heart failure. His innovative approach combines advanced genetic techniques with therapeutic applications.
Latest Patents
Horiguchi holds a patent for a method aimed at treating or preventing heart failure. The patent describes a pharmaceutical composition that includes a DNA sequence encoding RNA with a specific strand sequence derived from angiopoietin-like protein 2 (ANGPTL2) mRNA. This composition can be utilized alongside siRNA and a vector expressing said siRNA, providing a novel approach to combat heart failure. The patent highlights the potential of using an antisense strand sequence that is complementary to the sense strand sequence, all under the control of a promoter, along with a pharmaceutically acceptable carrier. He has 1 patent to his name.
Career Highlights
Horiguchi is affiliated with Kumamoto University, where he conducts his research and development work. His academic background and ongoing research contribute to advancements in medical science, particularly in cardiovascular health.
Collaborations
Horiguchi collaborates with esteemed colleagues, including Keishi Miyata and Tsuyoshi Kadomatsu. Their combined expertise enhances the research efforts and innovation in the field of heart disease treatment.
Conclusion
Haruki Horiguchi's work in developing methods for treating heart failure showcases his commitment to improving healthcare through innovation. His contributions are vital in the ongoing battle against cardiovascular diseases.